Mylan releases Fenoglide generic
PITTSBURGH — Mylan N.V. has launched fenofibrate tablets 40 mg and 120 mg, a cholesterol-lowering drug, in the United States. Mylan said Wednesday that its fenofibrate product is a generic version of Fenoglide tablets from Santarus. Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides and
